ORG Wealth Partners
TSHA icon

ORG Wealth Partners’s Taysha Gene Therapies TSHA Stock Holding History

ORG Wealth Partners’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$185 Buy
+38
New +$219 ﹤0.01% 2369

Other funds holding TSHA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ORG Wealth Partners's TSHA Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Taysha Gene Therapies (TSHA) in Q3 2026: 38 shares worth $185. The stake represents ﹤0.01% of the portfolio and ranks #2369 among its holdings.

87 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.

  • ORG Wealth Partners held 38 shares of Taysha Gene Therapies worth $185 as of Q3 2026.
  • Taysha Gene Therapies was a new ORG Wealth Partners position in Q3 2026.
  • Taysha Gene Therapies made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2369 holding.
  • 87 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.